A Study to Assess the Pharmacokinetics, Safety and Tolerability of Single-dose Adagrasib (BMS-986503) in Healthy Participants of Japanese Descent
Clinical trial NCT07723118 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07723118
- Sponsor
- Mirati Therapeutics Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-05
- Primary completion
- 2026-09-08
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.